C83.16

Mantle cell lymphoma, intrapelvic lymph nodes

Risk-adjusting (HCC)Billable code

HCC risk adjustment mapping

CMS-HCC V28

HCC20

Lung and Other Severe Cancers

CMS-HCC ESRD V24

HCC10

Lymphoma and Other Cancers

RxHCC V08

RXHCC19

Leukemias and Other Hematologic Cancers

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

Inherited from C83.1Mantle cell lymphoma
Synonyms

Centrocytic lymphoma Malignant lymphomatous polyposis

Inherited from C83Non-follicular lymphoma
Excludes 1

personal history of non-Hodgkin lymphoma (Z85.72)

Inherited from C81-C96Malignant neoplasms of lymphoid, hematopoietic and related tissue
Excludes 2

Kaposi's sarcoma of lymph nodes (C46.3) secondary and unspecified neoplasm of lymph nodes (C77.-) secondary neoplasm of bone marrow (C79.52) secondary neoplasm of spleen (C78.89)

Inherited from chapter 2Neoplasms
Note

Functional activity All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9). (C00-C96) Malignant neoplasms (C00-C96) (C00-C75) Malignant neoplasms, stated or presumed to be primary (of specified sites), and certain specified histologies, except neuroendocrine, and of lymphoid, hematopoietic and related tissue (C00-C75)

Official Guidelines for C83.16

FY 2026 ›

Sections that reference C83.16

Sections whose FY 2026 text names C83.16, its C83 category, or a range containing it — the chapter guidance above is the authoritative source.